Researchers at Albert Einstein College of Medicine of Yeshiva University have shown that close supervision by rheumatologists and the use of immunosuppressant drugs improve the survival of lupus patients with end-stage kidney disease - a finding that could reverse long-standing clinical practice. Their study appeared in the September 1 online edition of the Journal…